Other Regulatory Requirements. If the Bank is in default, as defined in Section (3)(x)(1) of the Federal Deposit Insurance Act, all obligations under this Agreement will terminate as the date of such default, but no vested rights of the Employee will be affected. Further, all obligations under this Agreement will be terminated, except, to the extent determined that continuation of the Agreement is necessary for the continued operation of the Bank:
Other Regulatory Requirements. Borrower and each of its Subsidiaries: (a) are and have been in material compliance with applicable health care laws, including, without limitation, the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 301 et seq.), the Federal Anti-kickback Statute (42 U.S.C. § 1320a-7b(b)), the Physician Payment Sunshine Act (42 U.S.C. § 1320a-7h), the civil False Claims Act (31 U.S.C. §§ 3729 et seq.), the administrative False Claims Law (42 U.S.C. § 1320a-7b(a)), the Anti-Inducement Law (42 U.S.C. § 1320a-7a(a)(5)), the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. § 1320d et seq.), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, the exclusion laws, Social Security Act § 1128 (42 U.S.C. § 1320a-7), Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the Social Security Act) and the regulations promulgated pursuant to such laws, and comparable state laws, and all other local, state, federal, national, supranational and foreign laws, and regulations relating to the regulation of Borrower and its Subsidiaries (collectively, “Health Care Laws”); (b) have not received written notice of any ongoing claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Regulatory Agency or third party alleging that any product operation or activity is in material violation of any Health Care Laws and has no knowledge that any such Regulatory Agency or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; and (c) are not a party to any corporate integrity agreement, deferred prosecution agreement, monitoring agreement, consent decree, settlement order or similar agreements or have any reporting obligations pursuant to any such agreement, plan or correction or other remedial measure entered into with any Governmental Authority. Neither Borrower nor its Subsidiaries or, to the knowledge of Borrower, any of their officers, directors, employees, agents or contractors has been or is currently debarred, suspended or excluded from participation in the Medicare and Medicaid programs or any other state or federal health care program.
Other Regulatory Requirements. 3.6.1. If Employee is removed and/or permanently prohibited from participating in the conduct of Employer's affairs by an order issued under section 8(e)(4) or (g)(1) of the Federal Deposit Insurance Act, all obligations of Employer under this Agreement shall terminate as of the effective date of the order, but vested rights of the Employer and Employee shall not be affected. If Employer is in default, as defined in Section (3)(x)(1) of the Federal Deposit Insurance Act, all obligations under this Agreement shall terminate as of the date of such default. Further, all obligations under this Agreement shall be terminated, except to the extent it is determined that continuation of the Agreement is necessary for the continued operation of Employer:
Other Regulatory Requirements. 39.1. The Licensee shall act with reasonable care and skill in performing its duties under this Agreement and shall not knowingly put any of the Operators in breach of any applicable legal or regulatory requirements when providing Train Service Information or selling a Rail Product or communicating with any purchaser or potential purchaser of such a Rail Product.
Other Regulatory Requirements. Each party agrees to reasonably cooperate with the other party in connection with the other party’s efforts to satisfy any regulatory requirements in connection with the transactions contemplated by this Agreement.
Other Regulatory Requirements. (a) If (i) the Bank is in default, as defined in Section (3)(x)(1) of the Federal Deposit Insurance Act, (ii) the Federal Deposit Insurance Corporation (or its successor) (the “FDIC”) or a court appoints a conservator or receiver for the Bank or (iii) the Commissioner of Financial Regulation for the State of Maryland takes possession of the Bank, then all obligations under this Agreement will terminate as of the date of such default, but no vested rights of the Executive will be affected. Further, all obligations under this Agreement will be terminated, except, to the extent it is determined that continuation of the Agreement is necessary for the continued operation of the Bank:
Other Regulatory Requirements. If the holder or, upon the advice of counsel, the Company determines that the exercise of this Warrant would require notice to, or the consent or approval by, the Federal Communications Commission or any public utility commission or other regulatory agency of any state in which the Company does business that is vested with jurisdiction over Company or the provision of communication services within such state, the holder and the Company shall make all necessary filings and notifications required, and shall have received any required consents, approvals, orders or otherwise, prior to effecting the exercise of this Warrant. The holder shall be required to pay all required filing fees in connection with such filings and notifications. Each holder by acceptance of a Warrant agrees to comply with the provisions of this Section 5(b).
Other Regulatory Requirements. If the Holder or, upon the advice of counsel, the Company, determines that the exercise of this Warrant would require prior notice to, or the consent or approval by, the Federal Communications Commission or any other regulatory agency that is vested with jurisdiction over the Company, the Holder and the Company shall make all necessary filings and notifications required, and shall have received all required consents, approvals, orders or otherwise, prior to effecting the exercise of this Warrant. The Company shall be required to pay all filing fees in connection with such filings and notifications.
Other Regulatory Requirements. The Parties shall enter into a suitable agreement with respect to pharmacovigilance and such other regulatory matters concerning the Exploitation of the Products in the Territory to the extent not expressly set out elsewhere in the Agreement, including procedures governing recalls, suspensions and withdrawals of Products in the Territory, within the timeline agreed by the Steering Committee (the “Pharmacovigilance and Regulatory Matters Agreement”), which, when agreed, shall be attached to this Agreement as Schedule [●]. CMS shall not, and shall cause the Designated Party not to, conduct any clinical development of a Product, or Commercialize any Products prior to the entry of Pharmacovigilance and Regulatory Matters Agreement. If and to the extent that (i) the Company or its Affiliate has first obtained a Regulatory Approval for a Product Switzerland, United Kingdom or in a country in the European Union in its name or in the United States (as applicable) and (ii) CMS selects to materialize its rights and interest in the Products and Acquired Assets under the Importation Paradigm, and (iii) under the Importation Paradigm, it is necessary for CMS or the Designated Party to have a Regulatory Approval for such Product in Switzerland, United Kingdom or a country in the European Union or in the United States (as applicable) to enable CMS to obtain or maintain a Regulatory Approval for such Product in the Territory, to the extent permitted by Applicable Laws and Regulations, CMS shall have the right to obtain in its name and maintain with necessary assistance of the Company a Duplicate Registration for such Product for the sole purpose of obtaining or maintaining a Regulatory Approval for such Product in the Territory, and provided that such Duplicate Registration does not limit in any material respect the Company’s ability to Exploit the Products outside the Territory. Any such Duplicate Registration shall be obtained or maintained by CMS in accordance with the form and substance of the corresponding Regulatory Approval for the Product, in Switzerland, United Kingdom or a country in the European Union (or, if applicable in the United States) held by the Company or its Affiliates, except for any necessary changes agreed by the Company in writing in advance. In the event that CMS is legally prohibited to obtain or maintain such Duplicate Registration, then CMS may, if permitted by the applicable law and regulations, cause such Duplicate Registration to be held on...
Other Regulatory Requirements. Seller and Buyer agree to cooperate with each other in connection with either's efforts to satisfy applicable regulatory requirements in connection with the transactions contemplated by this Agreement, each at its own cost and expense except as expressly provided otherwise in this Agreement.
